Zelira Therapeutics signs binding product development agreement with USA based CVSM
PERTH: Zelira Therapeutics Ltd, a global leader in the development of clinically validated cannabis medicines, has entered into a binding product development agreement with USA based Cardiovascular Solutions of Central Mississippi (CVSM) to target symptoms associated with Peripheral Arterial Disease…